Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT06826638
Recruiting
Unraveling Active Ingredients of Neurorehabilitation: Investigating Cortical Activity During Task-oriented Exercises
Not applicable · Italy · 3 sites
Registry update: 14 Feb 2025
NCT06567197
Recruiting
Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
Not applicable · Netherlands · 2 sites
Registry update: 22 Aug 2024
NCT05380856
Recruiting
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
Not applicable · Denmark · 1 site
Registry update: 16 Oct 2026
NCT06195800
Recruiting
Identifying Immune Biomarkers of Disease and Disease Control in Autoimmune Neurological Disease Using Autologous Haematopoietic Stem Cell Transplantation
Not applicable · United Kingdom · 1 site
Registry update: 7 Oct 2026
NCT05227092
Recruiting
3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)
Not applicable · France · 1 site
Registry update: 29 Jun 2025
NCT05359653
Recruiting
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Phase 1/2 · United States · 1 site
Registry update: 2 Jul 2026
NCT06016309
Recruiting
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
Not applicable · Netherlands · 1 site
Registry update: 30 Mar 2025
2024-518859-27-00
Recruiting
Effect of ozanimod on meningeal inflammation and glial activation in Multiple Sclerosis: one year phase 4 experimental study
Phase 4 · Italy · 1 site
Registry update: 11 Nov 2024
NCT04806620
Recruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Not applicable · United States · 1 site
Registry update: 22 Jan 2026
NCT06820125
Recruiting
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
Not applicable · Italy · 1 site
Registry update: 11 Feb 2025
NCT03974997
Recruiting
TWEAK, a New Biomarker for Predicting Inflammatory Relapses in Multiple Sclerosis
Not applicable · France · 1 site
Registry update: 23 Sept 2026
NCT05877963
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · Poland, United States · 47 sites
Registry update: 23 Oct 2026
NCT05758831
Recruiting
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Phase 3 · France · 26 sites
Registry update: 2 Feb 2026
Conflicting statuses (not updated in the registry for 9 months)
NCT06062693
Recruiting
New Interactive Sensor-home-based Hand Training to Improve Dexterity
Not applicable · Switzerland · 1 site
Registry update: 2 Oct 2023
NCT06343558
Recruiting
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Not applicable · Italy · 2 sites
Registry update: 3 Aug 2025
NCT05740722
Recruiting
Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
Phase 2 · Norway · 1 site
Registry update: 11 Jan 2024
NCT05934188
Recruiting
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Not applicable · Italy · 3 sites
Registry update: 9 Jan 2026
NCT05500963
Recruiting
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
Not applicable · United States · 1 site
Registry update: 9 Dec 2024
NCT05633875
Recruiting
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
Not applicable · France · 1 site
Registry update: 9 Dec 2025
NCT05491031
Recruiting
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
Not applicable · France · 1 site
Registry update: 5 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.